All Stories

  1. Clozapine-induced Myocarditis: Pathophysiologic Mechanisms and Implications for Therapeutic Approaches
  2. The Fundamental Basis of Palpitations: A Neurocardiology Approach
  3. Value of the New Spline QTc Formula in Adjusting for Pacing-Induced Changes in Heart Rate
  4. Considerations in Understanding the Coronary Blood Flow- Left Ventricular Mass Relationship in Patients with Hypertension
  5. The Impact of Left Ventricular Mass on Diastolic Blood Pressure Targets for Patients With Coronary Artery Disease
  6. Target blood pressure for patients with hypertension: Lower Blood Pressure is not better
  7. Newer QT Correction Formulae to Correct QT for Heart Rate Changes During Exercise
  8. Accentuating and Opposing Factors Leading to Development of Thoracic Aortic Aneurysms Not Due to Genetic or Inherited Conditions
  9. The Case Against Using Hypertension as the Only Criterion for Oral Anticoagulation in Atrial Fibrillation
  10. Modulation of the QT interval duration in hypertension with antihypertensive treatment
  11. Historical Biography for Translational Medicine: An Important Genre for Translational Science
  12. The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis
  13. Nonsustained monomorphic ventricular tachycardia following arousal from sleep after face trauma
  14. Nomenclature, categorization and usage of formulae to adjust QT interval for heart rate
  15. Differential expression of MMP-2, MMP-9 and TIMP proteins in thoracic aortic aneurysm – comparison with and without bicuspid aortic valve: a meta-analysis
  16. Role of neuropeptides in cardiomyopathies
  17. Dramatic lowering of very high Lp(a) in response to niacin
  18. The Relationship Between Epicardial Fat and Indices of Obesity and the Metabolic Syndrome: A Systematic Review and Meta-Analysis
  19. Epicardial Adipose Tissue and Reactive Oxygen Species
  20. Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease
  21. Renal Denervation Therapy for the Treatment of Resistant Hypertension: A Position Statement by the Canadian Hypertension Education Program
  22. Pulse Wave Velocity Involving Proximal Portions of the Aorta Correlates with the Degree of Aortic Dilatation at the Sinuses of Valsalva in Ascending Thoracic Aortic Aneurysms
  23. Aortic Wall Stress in Hypertension and Ascending Thoracic Aortic Aneurysms: Implications for Antihypertensive Therapy
  24. Differences in Coronary Blood Flow in Aortic Regurgitation and Systemic Arterial Hypertension Have Implications for Diastolic Blood Pressure Targets: A Systematic Review and Meta-Analysis
  25. Myocardial perfusion pressure in patients with hypertension and coronary artery disease
  26. Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy
  27. Brachial-Ankle Pulse Wave Velocity Is the Only Index of Arterial Stiffness That Correlates with a Mitral Valve Indices of Diastolic Dysfunction, but No Index Correlates with Left Atrial Size
  28. Correlation of pulse wave velocity with left ventricular mass in patients with hypertension once blood pressure has been normalized
  29. Comparison of vascular stiffness in vascular dementia, Alzheimer dementia and cognitive impairment
  30. Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease
  31. A strategy to improve hypertension control: The Canadian experience
  32. Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: The CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified T...
  33. Nitric oxide and peroxynitrite induce gene expression of interleukin receptors increasing IL-21, IL-7, IL-1 and oncostatin M in cardiomyocytes
  34. p38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) IS ACTIVATED BY NORADRENALINE AND SERVES A CARDIOPROTECTIVE ROLE, WHEREAS ADRENALINE INDUCES p38 MAPK DEPHOSPHORYLATION
  35. Stearic acid-induced cardiac lipotoxicity is independent of cellular lipid and is mitigated by the fatty acids oleic and capric acid but not by the PPAR agonist troglitazone
  36. Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
  37. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease
  38. Jumonji is a potential regulatory factor mediating nitric oxide-induced modulation of cardiac hypertrophy
  39. Apoptosis in Human Acute Myocardial Infarction: The Rationale for Clinical Trials of Apoptosis Inhibition in Acute Myocardial Infarction
  40. The metalloporphyrin FeTPPS but not by cyclosporin A antagonizes the interaction of peroxynitrate and hydrogen peroxide on cardiomyocyte cell death
  41. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death
  42. Metalloporphyrins as a therapeutic drug class against peroxynitrite in cardiovascular diseases involving ischemic reperfusion injury
  43. Palmitate-induced NO production has a dual action to reduce cell death through NO and accentuate cell death through peroxynitrite formation
  44. Interaction of the HMG-CoA Reductase Inhibitor Lovastatin and Nitric Oxide in Cardiomyocyte Cell Death
  45. Endogenous kappa opioids mediate the action of brain angiotensin II to increase blood pressure
  46. Sodium nitroprusside activates p38 mitogen activated protein kinase through a cGMP/PKG independent mechanism
  47. Nitric Oxide-Induced Cell Death in the Heart: The Role of Autophagy
  48. The Role of p53 in Nitric Oxide–Induced Cardiomyocyte Cell Death
  49. Omapatrilat enhances adrenomedullin's reduction of cardiomyocyte cell death
  50. Nitric oxide differentially regulates the gene expression of caspase genes but not some autophagic genes
  51. Reduction of protein synthesis and statin-induced cardiomyocyte cell death
  52. Effect of Amiodarone on Phospholipid Content and Composition in Heart, Lung, Kidney and Skeletal Muscle: Relationship to Alteration of Thyroid Function
  53. The association between RhoB and caspase-2: changes with lovastatin-induced apoptosis
  54. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: A potential mechanism for loss of mitochondrial transmembrane potential and apoptosis
  55. The association of hypertension and aortic valve sclerosis
  56. Reduction of palmitate-induced cardiac apoptosis by fenofibrate
  57. ADRENOMEDULLIN REDUCES CARDIOMYOCYTE CELL DEATH
  58. Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes
  59. Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors
  60. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus
  61. Mitochondrial effects with ceramide-induced cardiac apoptosis are different from those of palmitate
  62. Mechanisms of Palmitate-induced Cardiomyocyte Apoptosis
  63. Fumonisin blunts nitric oxide-induced and nitroprusside-induced cardiomyocyte death
  64. Lovastatin Induces Cell Death in Cardiomyocytes that Is Not Reversible by Coenzyme Q 10
  65. Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin
  66. Cardiac apoptosis induced by palmitate is mediated through mitochondrial carnitine palmitoyltransferase-1
  67. Prevention of Staurosporine-Induced Cell Death in Embryonic Chick Cardiomyocyte Is More Dependent on Caspase-2 Than Caspase-3 Inhibition and Is Independent of Sphingomyelinase Activation and Ceramide Generation
  68. Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes
  69. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A
  70. Nifedipine does not induce but rather prevents apoptosis in cardiomyocytes
  71. Thapsigargin Enhances Camptothecin-Induced Apoptosis in Cardiomyocytes
  72. Factors Associated With Implementation of Preventive Care Measures in Patients With Diabetes Mellitus
  73. Comparison of Angiotensin II Type-1 and Type-2 Receptor Antagonists on Angiotensin II– Induced IP3 Generation in Cardiomyocytes
  74. Translating Clinical Guidelines For Management of Heart Failure and Hypertension Into Clinical Practice
  75. Cardiac Angiotensin II Subtype 2 Receptor Signal Transduction Pathways: Embryonic Cardiomyocytes and Human Heart
  76. Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes
  77. The angiotensin II subtype 2 (AT 2 ) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte
  78. The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte
  79. Nifedipine does not alter the increased cystolic free magnesium during inhibition of mitochondrial function in isolated cardiac myocytes
  80. Effect of hypoxia on choline metabolism and phosphatidylcholine biosynthesis in isolated adult rat ventricular myocytes: effects of trifluoperazine
  81. Angiotensin II induced alteration of cyclic adenosine 3′,5′-monophosphate generation in the hypertrophic myocardium of Dahl salt-sensitive rat on a high-salt diet
  82. Verapamil Has Antiarrhythmic Effects That are Mediated in Brain Through Endogenous Opioids
  83. Indapamide alters the cyclic AMP signal transduction pathway in cardiomyocytes in culture
  84. Comparative effects of central administration of naloxone and clonidine on the blood pressure and heart rate response to anterior and posterior hypothalamic stimulation
  85. Effect of Indapamide on Cyclic Adenosine 3',5'-Monophosphate Signal Transduction System in Isolated Adult Rat Cardiomyocytes from Normal Myocardium and Cardiac Hypertrophy
  86. Comparative effects on blood pressure and heart rate of dynorphin A(1–13) in anterior hypothalamic area, posterior hypothalamic area, nucleus tractus solitarius, and lateral cerebral ventricle in the rat
  87. Lisinopril increases the recovery during reoxygenation and resistance to oxidative damage in cardiomyocytes
  88. Effect of exogenous CDP-choline on choline metabolism in isolated adult rat ventricular myocytes under normoxic and hypoxic conditions
  89. Comparison of indapamide and hydrochlorothiazide on spontaneous contraction of cardiomyocytes in culture: The effect on alterations of extracellular calcium or potassium
  90. Mechanisms of Action of Adrenergic Receptor Blockers on Lipids During Antihypertensive Drug Treatment
  91. MORPHINE AND MORPHICEPTIN INCREASE THE THRESHOLD FOR EPINEPHRINE-INDUCED CARDIAC ARRHYTHMIAS IN THE RAT THROUGH BRAIN MU OPIOID RECEPTORS
  92. Verapamil in the Brain Lowers Blood Pressure and Heart Rate Independent of Central Muscarinic Receptors.
  93. The opioid agonist ethylketocyclazocine accentuates epinephrine-induced cardiac arrhythmias in the rat through an action in the brain
  94. Effect of Indapamide on Cyclic Adenosine 3',5'-Monophosphate Signal Transduction System in Isolated Adult Rat Cardiomyocytes from Normal Myocardium and Cardiac Hypertrophy
  95. Morphine and the Endogenous Opioid Dynorphin in the Brain Attenuate Digoxin-Induced Arrhythmias in Guinea Pigs
  96. Dynorphin A (1–13) in the brain suppresses epinephrine-induced ventricular premature complexes and ventricular tachyarrhythmias
  97. Cilazapril and Captopril Accelerate Recovery from Hypoxia in Myocardial Cell Aggregates in Culture
  98. Regulation by angiotensin II of phosphate transport in cardiac myocytes
  99. DILTIAZEM AND VERAPAMIL LOWER BLOOD PRESSURE IN THE UNANAESTHETIZED RAT THROUGH CNS MECHANISMS INVOLVING ENDOGENOUS OPIOIDS
  100. Angiotensin in the brain suppresses epinephrine-induced cardiac arrhythmias through CNS opioid mechanisms
  101. Cardiorespiratory Responses to D-Ala-2-Me-Phe-4-Met-(O)-ol-Enkephalin after Administration into the Fourth Cerebral Ventricle of the Rat: Interaction with Cholinergic Mechanisms
  102. d-Ala-2-Me-Phe-4-Met-(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depression
  103. The Effect of Amiloride on the Cardiac Chronotropic Responses to Isoproterenol in Myocardial Aggregate Cells in Culture
  104. The effect of alteration of extracellular Na+ or Ca2+ and inhibition of Ca2+ entry, Na+H+ exchange, and Na+Ca2+ exchange by diltiazem, amiloride, and dichlorobenzamil on the response of cardiac cell aggregates to epidermal growth factor
  105. Cytosolic free magnesium in cardiac myocytes: Identification of a Mg2+ influx pathway
  106. The effect of inhibitors of endogenous opioid degradation, bacitracin, bestatin, captopril, and D -phenylalanine, on digoxin-induced arrhythmias in guinea pigs
  107. Effects of chlorpromazine and trifluoperazine on choline metabolism and phosphatidylcholine biosynthesis in cultured chick heart cells under normoxic and anoxic conditions
  108. Comparison of the Effect of Amiloride and Its Analogue Dichlorobenzamil on Cardiac Chronotropic Responses to Ouabain in Myocardial Cell Aggregates in Culture
  109. Modelling of the heart and pericardium at end-diastole
  110. The effect of amiloride and its analog dichlorobenzamil on the cardiac chronotropic responses of myocardial cell aggregates in culture to alterations of extracellular potassium or calcium
  111. Effect of D-Ala-2-Me-Phe-4-Gly-ol-5 enkephalin on epinephrine-induced arrhythmias in the rat and the interrelationship to the parasympathetic nervous system
  112. Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia
  113. THE INTERRELATIONSHIP OF MORPHINE AND THE PARASYMPATHETIC NERVOUS SYSTEM IN DIGOXIN-INDUCED ARRHYTHMIAS IN THE GUINEA-PIG
  114. Effect of cAMP on choline uptake and phosphatidylcholine biosynthesis in cultured chick heart cells
  115. The effect of D-Ala-2-Me-Phe-4-Met-(O)-OL enkephalin on blood pressure, heart rate and digoxin-induced arrhythmias in the guinea pig
  116. Effect of Chronic Diuretics on Epinephrine-Induced Ventricular Arrhythmias
  117. The effect of epidermal growth factor on chronotropic response in cardiac cells in culture
  118. Effect of Chlorpromazine on Myocardial Damage in the Calcium Paradox
  119. Effect of the opiate antagonist naloxone on digitalis induced cardiac arrhythmias
  120. Health beliefs as predictors of success of alternate modalities of smoking cessation: Results of a controlled trial
  121. Session on sodium and calcium in the management of hypertension summary of remarks of discussant and chairman
  122. Mitochondrial and cytoplasmic aspartate aminotransferase enzyme release in the calcium paradox
  123. Effect of naloxone on exercise-induced angina pectoris: A randomized double blind crossover trial
  124. Adriamycin cardiomyopathy: Implications of cellular changes in a canine model with mild impairment of left ventricular function
  125. Beneficial Effects of Streptokinase on Left Ventricular Function After Myocardial Reoxygenation and Reperfusion Following Global Ischemia in the Isolated Rabbit Heart
  126. Mitochondrial and cytoplasmic isoenzymes of aspartate aminotransferase in sera of patients after myocardial infarction
  127. Electrocardiographic Abnormalities in Apparently Healthy Men and the Risk of Sudden Death
  128. A randomized trial comparing smoking cessation programs utilizing behaviour modification, health education or hypnosis
  129. Interaction of External Calcium Concentration and Verapamil on the Effects of Doxorubicin (Adriamycin) in the Isolated Heart Preparation
  130. Increased mortality with cardiotoxic doses of Adriamycin after verapamil pretreatment despite prevention of myocardial calcium accumulation
  131. Changes in High Density Lipoprotein Cholesterol after Initiation of Insulin Therapy in Non-Insulin Dependent Diabetes Mellitus: Relationship to Changes in Body Weight
  132. Predictors of outcome in a risk factor intervention trial using behavior modification
  133. A classification of ventricular ectopic beats
  134. Effects of Doxorubicin (Adriamycin) on Systemic Hemodynamics and Myocardial Blood Flow1
  135. Effect of Angiotensin-Converting Enzyme Inhibition by Captopril on Cardiac Output, Coronary Blood Flow, and Systemic Arterial Blood Pressure in the Intact and in the Bilaterally Nephrectomized Rabbit
  136. The Natural History of Right Bundle Branch Block and Frontal Plane QRS Axis in Apparently Healthy Men
  137. Relationship of ventricular ectopy in men without apparent heart disease to occurrence of ischemic heart disease and sudden death
  138. The relationship of marked left axis deviation to the risk of ischemic heart disease
  139. Long term followup of incomplete right bundle branch block: The risk of development of complete right bundle branch block
  140. Role of the pericardium and intact chest wall in the hemodynamic response to positive end-expiratory pressure ventilation
  141. Chronobiology of Cardiac Sudden Death in Men
  142. COMPARISON OF HAEMODYNAMIC RESPONSES TO POSITIVE-END-EXPIRATORY VENTILATION AND PERICARDIAL EFFUSION IN DOGS
  143. Natural history of marked left axis deviation (left anterior hemiblock)
  144. The Relation of Blood Pressure to Stroke Prognosis
  145. Predicting Risk of Ischemic Heart Disease and Cerebrovascular Disease from Systolic and Diastolic Blood Pressures
  146. Prognosis after acute myocardial infarction: Relation to blood pressure values before infarction in a prospective cardiovascular study
  147. Change in risk factor and the development of chronic disease. A methodological illustration
  148. Relation of body weight to development of ischemic heart disease in a cohort of young north American men after a 26 year observation period: The manitoba study
  149. Chronic Postrheumatic Arthropathy (Type Jaccoud)